Diffuse Large B-Cell Lymphoma CNS Relapse Prophylaxis with Intrathecal or High-Dose Intravenous Methotrexate

被引：0
|
作者：
Zhou, Edward [1 ]
Zheng, Kelvin [2 ]
Phyu Thin Naing [1 ]
Boisclair, Stephanie [3 ]
Goldberg, Bradley [4 ]
机构：
[1] Zuckerberg Canc Ctr, New Hyde Pk, NY USA
[2] Northwell Hlth, Internal Med, Manhasset, NY USA
[3] Northwell Hlth, Zuckerberg Canc Ctr, Lake Success, NY USA
[4] Zuckerberg Canc Ctr, Lake Success, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-172831
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma
    Conconi, Annarita
    Chiappella, Annalisa
    Ferreri, Andres J. M.
    Stathis, Anastasios
    Botto, Barbara
    Sassone, Marianna
    Gaidano, Gianluca
    Balzarotti, Monica
    Merli, Francesco
    Tucci, Alessandra
    Vanazzi, Anna
    Tani, Monica
    Bruna, Riccardo
    Orsucci, Lorella
    Cabras, Maria Giuseppina
    Celli, Melania
    Annibali, Ombretta
    Liberati, Anna Marina
    Zanni, Manuela
    Ghiggi, Chiara
    Pisani, Francesco
    Pinotti, Graziella
    Dore, Fausto
    Esposito, Fabiana
    Pirosa, Maria Cristina
    Cesaretti, Marina
    Bonomini, Luisella
    Vitolo, Umberto
    Zucca, Emanuele
    BLOOD ADVANCES, 2024, 8 (06) : 1541 - 1549
  • [32] The role of CNS prophylaxis in diffuse large B-cell lymphoma (DLBCL)
    Korfel, A.
    ONKOLOGIE, 2010, 33 : 26 - 27
  • [33] Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma
    Abramson, Jeremy S.
    Hellmann, Matthew
    Barnes, Jeffrey A.
    Hammerman, Peter
    Toomey, Christiana
    Takvorian, Tak
    Muzikansky, Alona
    Hochberg, Ephraim P.
    CANCER, 2010, 116 (18) : 4283 - 4290
  • [34] Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma
    O'Rourke, Kacey
    Morris, Kirk
    Kennedy, Glen A.
    CANCER, 2011, 117 (11) : 2579 - 2580
  • [35] High-dose methotrexate and ifosfamide for CNS relapse of aggressive lymphoma
    Fischer, L.
    Korfel, A.
    Jahnke, K.
    Kiewe, P.
    Thiel, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Prophylactic high-dose methotrexate in diffuse large B cell lymphoma, authors' response
    Puckrin, Robert
    Stewart, Douglas A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : E339 - E341
  • [37] The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma
    Arkenau, H. -T.
    Chong, G.
    Cunningham, D.
    Watkins, D.
    Agarwal, R.
    Sirohi, B.
    Trumper, M.
    Norman, A.
    Wotherspoon, A.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2007, 18 (03) : 541 - 545
  • [38] Patient Selection for High-Dose Methotrexate As Central Nervous System Prophylaxis in Diffuse Large B-Cell Lymphoma in Australia: Are We Getting It Right?
    Garwood, Melissa
    Hawkes, Eliza A.
    Churilov, Leonid
    Grigg, Andrew
    Chong, Geoff
    BLOOD, 2016, 128 (22)
  • [39] Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required
    Martinez-Calle, Nicolas
    Wilson, Matthew R.
    Eyre, Toby A.
    Cwynarski, Kate
    McKay, Pamela
    Fox, Christopher P.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (09) : E338 - E339
  • [40] Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies
    Savage, Kerry J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 578 - 586
12345